Additional Exempt Distributions
|
2
|
Zenith Epigenetics
|
Sep 17, 2023 04:45PM
|
Re: Add one to the list
|
3
|
Zenith Epigenetics
|
Sep 13, 2023 11:47AM
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
4
|
Resverlogix Corp.
|
Aug 29, 2023 03:00PM
|
Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
2
|
Resverlogix Corp.
|
Aug 29, 2023 07:27AM
|
Re: Bouncing off the 52 week low..
|
4
|
Resverlogix Corp.
|
Aug 25, 2023 03:39PM
|
Re: Bouncing off the 52 week low..
|
|
Resverlogix Corp.
|
Aug 25, 2023 12:14PM
|
Re: I believe the big/long wait
|
2
|
Resverlogix Corp.
|
Aug 25, 2023 11:29AM
|
Re: I believe the big/long wait
|
1
|
Resverlogix Corp.
|
Aug 23, 2023 04:11PM
|
Re: AGM Oct 26, 2023
|
4
|
Zenith Epigenetics
|
Aug 14, 2023 11:09AM
|
Re: Financial Statement Q2, 2023 /MD&A
|
2
|
Resverlogix Corp.
|
Aug 14, 2023 08:37AM
|
Re: Financial Statement Q2, 2023 /MD&A
|
2
|
Resverlogix Corp.
|
Aug 13, 2023 11:19AM
|
Financial Statement Q2, 2023 /MD&A
|
2
|
Resverlogix Corp.
|
Aug 12, 2023 08:50AM
|
Re: New SEDAR page
|
|
Zenith Epigenetics
|
Aug 10, 2023 08:15AM
|
Re: Are big things about tp happen regarding xB3?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 09, 2023 12:16PM
|
Re: New SEDAR page
|
1
|
Zenith Epigenetics
|
Aug 06, 2023 07:54AM
|
Re: Long covid trials
|
1
|
Resverlogix Corp.
|
Aug 03, 2023 11:20AM
|
Re: New SEDAR page
|
|
Zenith Epigenetics
|
Aug 03, 2023 11:06AM
|
Re: Long covid trials
|
1
|
Resverlogix Corp.
|
Aug 03, 2023 07:23AM
|
Re: Long Covid remains a big challenge
|
|
Resverlogix Corp.
|
Jul 25, 2023 08:30AM
|
Re: Additional Reports of Exempt Distribution
|
1
|
Zenith Epigenetics
|
Jul 22, 2023 11:48AM
|